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Abstract
Background: Skin aging is associated with intrinsic processes that compromise the structure of the extracellular matrix
while promoting loss of functional and regenerative capacity. These processes are accompanied by a large-scale shift in
gene expression, but underlying mechanisms are not understood and conservation of these mechanisms between humans
and mice is uncertain.
Results: We used genome-wide expression profiling to investigate the aging skin transcriptome. In humans, age-related
shifts in gene expression were sex-specific. In females, aging increased expression of transcripts associated with T-cells, B-
cells and dendritic cells, and decreased expression of genes in regions with elevated Zeb1, AP-2 and YY1 motif density. In
males, however, these effects were contrasting or absent. When age-associated gene expression patterns in human skin
were compared to those in tail skin from CB6F1 mice, overall human-mouse correspondence was weak. Moreover,
inflammatory gene expression patterns were not induced with aging of mouse tail skin, and well-known aging biomarkers
were in fact decreased (e.g., Clec7a, Lyz1 and Lyz2). These unexpected patterns and weak human-mouse correspondence
may be due to decreased abundance of antigen presenting cells in mouse tail skin with age.
Conclusions: Aging is generally associated with a pro-inflammatory state, but we have identified an exception to this
pattern with aging of CB6F1 mouse tail skin. Aging therefore does not uniformly heighten inflammatory status across all
mouse tissues. Furthermore, we identified both intercellular and intracellular mechanisms of transcriptome aging, including
those that are sex- and species-specific.
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Introduction
Intrinsic skin aging is characterized by the progressive accumu-
lation of senescent cells, thinning of the epidermis, decline in cell-to-
cell adherence, reduction of collagen content, formation of fine
wrinkles, and gradual loss of elastic material [1,2]. These features of
normal skin aging can compromise health and well-being at older
ages. Skin from older individuals, for instance, can lack the
regenerative capacity required for wound healing and may provide
a weakened immune barrier against pathogens, while also
exhibiting an increased burden of somatic mutations that heightens
susceptibility to melanomas and squamous cell carcinoma [1–5].
Senescent decline in skin function is simultaneous with broader
systemic effects of normal aging, which involve diminished capacity
to maintain homeostasis and overall loss of physiological reserve.
The inter- and intra-cellular events associated with intrinsic skin
aging parallel this broader aging process in certain respects,
providing a model system to study mechanisms of aging [6]. In
older individuals, for instance, the area occupied by elastic fibers in
stained tissue sections is correlated between the reticular dermis and
temporal artery, representing an extra-cellular feature of aging that
is shared between the integumentary and vascular systems [7].
H e a l t ha n da p p e a r a n c eo fh u m a ns k i nw i t ha g ei sc l o s e l yl i n k e dt o
the synthesis of collagen and mechanisms that maintain the integrity
of this abundant protein throughout the lifespan. With increasing age,
abundance of both transforming growth factor b (TGF-b)a n d
connectivetissuegrowthfactor(CTGF)declinesindermalfibroblasts,
which contributes to reduced collagen synthesis and secretion [8].
Additionally, type I collagen fibrils become increasingly fragmented
due to a self-perpetuating cycle in which increased oxidant levels
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33204promote an AP-1 and a2b1 integrin-dependent elevation of matrix
metalloproteinase 1(MMP-1)expression,andinturnMMP-1cleaves
extracellular collagen, resulting in loss of mechanical tension in
dermal fibroblasts [9]. This loss of mechanical tension leads to greater
production of intracellular oxidants within fibroblasts, which further
heightens MMP-1 activity and reinforces the cycle by which
extracellular matrix is degraded in aging skin [9]. The importance
of these processes to aging is not restricted to skin alone. In heart, for
instance, heighted TGF-b activity and excess collagen deposition are
factors that promote fibrotic disease, which can decrease elasticity of
ventricular walls and compromise contractile function [10]. In mice,
shifts in the expression of procollagen-encoding genes (Col1a2 and
Col3a1) with age are among the most well-supported and widespread
of all age-associated gene expression patterns [11]. These alterations
in procollagen gene expression may, in part, reflect age-related
attenuation of estrogen, growth hormone and/or insulin-like growth
factor endocrine pathways [6,12–16].
Genome-wide expression profiling provides broad insights that
can assist development of more comprehensive skin aging models
[17–20]. Such investigations have identified unexpected and
previously unknown effects of intrinsic skin aging, but require
extension in several ways. First, expression profiling studies have
primarily focused on one sex (males) [17,18], but effects of aging
on gene expression in humans can be sex-specific [21,22]. Second,
while the influence of aging among mammalian cell types and
organ systems is partly overlapping and partly tissue-specific
[11,23,24], it is unclear which aspects of skin aging are among the
core senescent processes that influence other organ systems, which
might be broadly targeted by therapeutic compounds that prevent
or delay onset of age-related conditions [25,26]. Third, although
large-scale shifts in gene expression occur with intrinsic skin aging,
mechanistic underpinnings of these transcriptional changes remain
unclear. On the one hand, the aging skin transcriptome is shaped
by intracellular events and the activation or inhibition of
transcription factors, such as ETS1, ETS2, AP-1, p53, E2F1 and
NF-kB [8,19,27,28]. At the same time, extracellular features of
skin aging also influence the composition of RNA species within
aging skin. These features include degradation of the extracellular
matrix [9], decline in the average diameter of blood vessels [29],
and inflammatory events with infiltration of aging tissues by, for
example, macrophages, T-cells, B-cells, natural killer cells, and
neutrophils [30]. A complete mechanistic model must tie together
the major intracellular and intercellular features of skin aging, and
a key challenge is development of analytical pipelines that can
exploit large-scale genomic datasets for this purpose.
We used Affymetrix high density oligonucleotide arrays to
provide a comprehensive analysis of transcriptome aging in sun-
protected skin obtained from female and male human subjects, as
well as in tail skin from CB6F1 mice of both sexes. We investigate
broad correspondence between effects of natural aging in human
and mouse skin. By analyzing transcriptome data within a meta-
analysis framework, we highlight intrinsic features of skin aging
that are closely tied to basic aging mechanisms, with the aim of
establishing skin aging biomarkers that are best supported by
existing data. In silico approaches are also used to identify both
intercellular (inflammatory) and intracellular (cis-regulatory)
mechanisms that underlie expression changes associated with
advancing age, and our findings provide support for mechanisms
that are sex-specific and/or species-specific.
Results
In silico inflammation profiling uncovers female-specific
elevation of lymphocyte signatures with intrinsic aging
of human skin
Genes for which expression is altered by aging in sun-protected
skin (buttock and upper thigh) were identified from analysis of 31
female subjects (ages 18–75) and 31 male subjects (ages 18–60)
(Table S1). Expression signatures of aging in female and male skin
were compared with those generated from 25 other datasets,
where each dataset included expression measurements from a
combination of young and old subjects (e.g., airway epithelia,
trachea, muscle, blood and central nervous system; all data were
generated using the same Affymetrix Human Genome U133 Plus
2.0 platform; total of 573 arrays; Figure S1 and Table S1). From
this integrative analysis, a partially overlapping set of gene
expression responses to aging in skin and other organ systems
could be discerned (Figure S1). For instance, among the top 50
genes increased by aging most frequently across tissues, 32 were
also increased in female and/or male skin (e.g., CLU, DSE, MT2A;
see Figure S1A). Likewise, among the top 50 genes most often
decreased by aging, 24 were correspondingly decreased in female
and/or male skin (e.g., CA11, CHST2, DCAF11; see Figure S1B).
However, based upon analysis of overrepresented Gene Ontology
(GO) terms, it was also clear that many effects of aging in human
skin were sex-specific. In females, for instance, aging decreased
expression of genes associated with diverse metabolic processes
(e.g., ATP, acetyl-CoA and alkaloid metabolism), but such genes
were not correspondingly decreased in males (Figure S2B).
In males, but not females, aging decreased expression of genes
associated with immune-related GO terms (e.g., immune response,
cellular defense, antigen processing and presentation; Figure S2D).
This pattern could be due to sex differences in inflammatory
events and localized shifts in lymphocyte abundance with
advancing age [30]. To evaluate this possibility, we applied an
algorithm for generating ‘‘inflammation profiles’’ based on
microarray data, which focuses on ‘‘signature transcripts’’ highly
expressed in immunocyte populations (or other cell types) in order
to gauge whether there exists significant evidence for shifts in cell
type abundance between two groups (e.g., young and old) [31].
This approach detects directional bias in the effects of aging
among signature transcripts associated with specific cell types, and
uses this information to infer shifts in cell type abundance with
increased age (see Methods and Figure 2 from Swindell et al. [31]).
For both female and male skin, transcripts with high expression in
adipose tissue increased with age, supporting expansion of the
subcutaneous adipose tissue compartment in both sexes (Figure 1).
However, divergent inflammatory patterns in females relative to
males were identified (Figures 1 and 2). In females, aging increased
expression of transcripts associated with CD3+ T-cells, CD4+ T-
cells, CD8+ T-cells, B-cells, macrophages, dendritic cells,
monocytes and neutrophils (Figures 1 and 2). In males, these
patterns were absent, and in contrast, there was evidence for
decreased expression of transcripts associated with CD3+ T-cells,
CD4+ T-cells, CD8+ T-cells and B-cells (Figures 1 and 2). More
broadly, the female signature closely paralleled those observed in
skeletal muscle and central nervous system regions, while that of
males was more similar to airway epithelia, trachea and whole
blood (Figure 1).
Mechanisms of Transcriptome Aging
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associations with the expression profile of intrinsic
human skin aging
The intracellular expression response to aging is coordinated, in
part, by the activation or repression of transcription by sequence-
specific transcription factors [8,19,27]. To identify candidate
transcriptional regulators in aging skin, we assembled a dictionary
of 541 DNA binding site motifs for mammalian transcription
factors from the UniPROBE and Jaspar databases [32–34], and
investigated whether abundance of each individual motif within
2 kb upstream and 200 bp downstream of transcription start sites
was associated with increased or decreased expression with age
Figure 1. In silico inflammation profiles of aging in human tissues: Sex-specific lymphocyte signatures in skin. An algorithm for
calculation of inflammation profiles based on microarray data was used to establish a gene expression-based mapping of inflammation events
associated with aging in human skin and other tissue types (see Methods section and Figure 2 from Swindell et al. [31]). Colors reflect age-associated
gene expression patterns among ‘‘signature transcripts’’ that exhibit elevated expression in different cell populations (listed in left margin). Dark red
colors indicate cases in which signature transcripts for a given cell population increase with age (i.e., the ratio of age-increased to age-decreased
signature transcripts is greater than one). Filled black circles indicate significant bias towards age-increased expression among signature transcripts
(FDR-adjusted P,0.05; Fisher’s exact test), suggesting increased abundance or infiltration of that cell population with aging. The opposite pattern, in
which signature transcripts are disproportionately decreased with age, is indicated by green squares within the chart (indicative of decreased cell
type abundance with age). For most cell population categories (rows), data from multiple cell populations was available, which permitted calculation
of several signature transcript ratios (r1, r2…rn). In these cases, the maximum ratio is displayed in the chart if the median value of r1, r2… rn is greater
than 0.50 (since, in this case, most evidence suggests bias towards age-increased expression among the n replicate sets of signature transcripts). The
minimum ratio is displayed if the median value of r1, r2… rn is less than 0.50 (since, in this case, most evidence suggests bias towards age-decreased
expression among the n replicate sets of signature transcripts).
doi:10.1371/journal.pone.0033204.g001
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were associated with age-increased expression in both sexes
(Figures S3A, S3C, S4A and S4C). However, among top-ranked
motif-expression associations, these were the only patterns
consistent between sexes (Figures S3 and S4). One top-scoring
motif – for the TF Nfe2l1 – was associated with age-decreased
expression in females but in contrast was associated with age-
increased expression in males (see magenta labels in left margin of
Figures S3B, S3C, S4B and S4C). Thus, sex-dependence was
noted with respect to both inflammatory and putative cis-
regulatory mechanisms in humans (Figures 1, S3 and S4).
We further investigated the associations between gene expres-
sion and motif density observed for putative Zeb1 (zinc finger E-
box binding homeobox 1), AP-2 (transcription factor AP-2 alpha)
and YY1 (Yin and Yang 1) DNA binding site motifs (Figures S3B
and S4B). In each case, a larger number of motif occurrences near
the transcription start site (2000 BP upstream to 200 BP
downstream) was associated with decreased expression in aging
female skin, but trends were attenuated or contrasting in male skin
(Figure S5). These female-specific motif associations were further
supported based upon analysis of intergenic sequences, intronic
sequences and TSS-proximal sequences conserved among verte-
brate species (see Methods; results for AP-2 are shown in Figure
S6). With respect to intronic regions, associations between Zeb1,
AP-2 and YY1 motifs and age-related expression diverged sharply
between sexes, with significant but opposite patterns in females
relative to males (Figures S6E–S6H).
Figure 2. Signature transcripts of CD4+ T-cells exhibit sex-specific shifts in gene expression with age in human skin. We identified 500
probe sets (from the Affymetrix Human Genome U133 Plus 2.0 array) representing signature transcripts that exhibit high expression in CD4+ T-cells
isolated from peripheral blood (based on data obtained under GEO series accession GSE14278). Scatterplots (A) and (C) display expression of these
transcripts in skin samples from young and old human subjects. Red symbols represent probe sets with higher expression in old subjects, and green
symbols represent probe sets with higher expression in young subjects. The relative proportion of these two probe set groups is indicated by the pie
chart shown in each figure. In (A) (females), young subjects were between 18 and 22 years of age (n=5) and old subjects were between 57 and 75
years of age (n=5). In (C) (males), young subjects were between 18 and 27 years of age (n=5) and old subjects were between 57 and 60 years of age
(n=5). Among all T-cell-associated probe sets, the average increase in old subjects was 11% in females, but in males, T-cell-associated probe sets
decreased by 5.3% on average (P,0.001; two-sample t-test). Across all probe sets, moreover, fold-change differences between old and young mice
were negatively correlated between the sexes (r=20.13, P,0.001). In parts (B) and (D), subjects were divided into different age groups (n=2–3
subjects per group). 40-year fold-change estimates (old/young) were then averaged across subjects belonging to the same age group for each of the
500 probe sets associated with the CD4+ T-cell signature. Grey boxes denote the median and inter-quartile range for the 500 fold-change estimates in
each age group. The red background region denotes an average fold-change larger than one (i.e., signature transcripts are age-increased on average),
while the green background region denotes an average fold-change less than one (i.e., signature transcripts are age-decreased on average).
doi:10.1371/journal.pone.0033204.g002
Mechanisms of Transcriptome Aging
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human sun-protected skin and tail skin from CB6F1 mice
in both sexes
A previous investigation of aging in brain, muscle and kidney
found limited correspondence between age-related expression
profiles in humans and inbred C57BL/6 mice [24]. We thus
evaluated gene expression in tail skin of young (5 month) and old
(30 month) CB6F1 hybrid mice of both sexes (n=5 per age-sex
combination; Affymetrix Mouse Genome 430 2.0 Array platform).
Inspection of aging signatures, including mouse and human skin
combined with other mammalian tissues, highlighted a general
pattern by which aging patterns in human tissues clustered
together with each other and apart from those of mouse tissues
(Figure 3). The human and mouse fold-change estimates (old/
young) were negatively correlated or uncorrelated (Pearson
r=20.096 in females, P,0.001; r=20.002 in males, P=0.77;
see Figure 4). This lack of significant similarity was confirmed
based upon three other analytical methods, including examination
of differential expression signature overlap [11] (Figure S7), rank-
based AUC statistics [35] (P$0.136; Figure S8) and gene set
enrichment analysis [36] (P$0.51; Figure S9). Global effects of
aging on gene expression in CB6F1 mouse tail skin therefore do
not have significant similarity to those in sun-protected human
skin.
Aging does not increase expression of Lyz1, Lyz2, Clec7a,
Cd48, Tyrobp and Mpeg1 in tail skin of male and female
CB6F1 mice
A robust and striking effect of aging in laboratory mice is elevated
expression of genes associated with immune activation, including
cathepsin S (Ctss), complement components (e.g., C1qa), cluster of
differentiation antigens (Cd48) and lysozyme (Lyz1 and Lyz2) (see
Figure 6 from [11]). We compared genes regulated by aging in
mouse tail skin with age-regulated genes identified in 28 other
datasets with young and old samples from a diverse panel of mouse
tissues (e.g., lung, liver, kidney, spleen, aorta, muscle, heart, cochlea,
eye and central nervous system; all studies used the same Affymetrix
Mouse Genome 430 2.0 platform; total of 295 arrays; Figures 5 and
S10; Table S2). As expected, the most consistent effect of aging in
mouse tissues was elevated expression of membrane-associated
immune response genes, including glycoprotein 49 A (Gp49a),
lysosomal-associated protein transmembrane 5 (Laptm5), CD52
antigen (Cd52), CD53 antigen (Cd53), C-type lectin domain family 7
member a (Clec7a), lysozyme 1 (Lyz1) and lysozyme 2 (Lyz2) (see
Figure 5). Strikingly, however, in mouse tail skin, expression of these
genes was decreased, in both sexes, but particularly in females
(Figure 5). This aberrant pattern was further illustrated by
inspection of genes associated with specific immune-associated
GO terms (e.g., activation of immune response, positive regulation
of defense response, acute inflammatory response), which were
decreased with age in CB6F1 tail skin, but increased in most other
mouse tissues (see Figure S11B). We confirmed by quantitative RT-
PCR that expression of Clec7a, Lyz1 and Lyz2 was decreased with
age in mouse tail skin (Figures 6, S12 and S13). Further evaluation
indicated that the pattern was specific to tail skin and not, for
instance, an unusual aging effect in CB6F1 mice. In particular, one
or more of the evaluated genes (Clec7a, Lyz1 and Lyz2)w a s
significantly elevated with age in ear skin, heart, lung, kidney and
small intestine of CB6F1 mice (Figures 6, S12 and S13).
Aging of tail skin in CB6F1 mice promotes decreased
expression of transcripts associated with antigen
presenting cells in both sexes
C-type lectin domain family 7 (Clec7a/Dectin-1) was unexpect-
edly decreased by aging in mouse tail skin (Figures 5 and 6) and is
expressed at high levels in leukocyte subsets, including dendritic
cells, macrophages, monocytes and neutrophils [37]. We thus
hypothesized that mouse tail skin would exhibit concerted declines
in the expression of transcripts associated with specific lymphocyte
subsets. Consistent with this, inflammation profiles indicated
decreased expression of transcripts associated with antigen
presenting cells (APC; DC and macrophages) in old mouse tail
skin as compared to young skin (both sexes), along with weak
elevation of transcripts associated with CD4+ T-cells (Figures 7
and S14). This decline contrasted with a general trend observed
across mouse tissues, in which APC-associated transcripts were
frequently elevated with age (Figure 7). Moreover, although aging
decreased expression of genes expressed in the T- and B-cell
subsets in human males, an age-related decrease in the expression
of transcripts associated with APC was not noted in either female
or male human skin (Figure 1). Thus, differential age-related
declines in DC and macrophage-associated expression contribute
to divergent effects of transcriptome aging in human skin and
CB6F1 tail skin (Figures 3 and 4).
Zeb1 and Prrx2 DNA binding site motifs are associated
with gene expression changes with aging of CB6F1
mouse tail skin
We screened 541 mammalian transcription factor DNA binding
site motifs for association with gene expression changes in tail skin
from aging mice (Figures 8 and S15). As compared to humans
(Figure S3 and S4), consistent trends between species included age-
increased expression of genes associated with elevated myeloid
zinc finger 1 (Mzf1) and SRY-box 10 (Sox10) binding site density
in males (Figures 8C and S15C; blue labels). Notably, however, we
identified five motifs associated with age-increased expression in
tail skin from female CB6F1 mice, but age-decreased expression in
human females (i.e., AP-2, Myb, Myc, Nr4a2 and Zeb1;
Figures 8A and S15A), along with two motifs associated with
age-decreased expression in female mice but age-increased expres-
sion in human females (i.e., Nkx2 and Nobox; Figures 8B and
S15B). Moreover, in males, two motifs were linked with age-
decreased expression in mice but age-increased expression in
humans (i.e., Foxl1 and Gata2; Figures 8D and S15D). Thus, in
line with the lack of correspondence between age-associated gene
expression patterns in humans and mice (Figures 3 and 4), as well
as disparate shifts in inflammatory gene expression patterns with
aging in each system (Figures 1 and 7), we identified contrasting
motif-expression associations with aging of human and mouse skin.
In mice, motifs strongly associated with tail skin aging included
Zeb1 (zinc finger E-box binding homeobox 1) and Prrx2 (paired
related homeobox 2) (Figures 8 and S15). These motif-expression
associations were consistent between mouse sexes, with the Zeb1
motif linked to increased expression with age, and the Prrx2 motif
linked to decreased expression with age (Figure S16). In each case,
moreover, a similar motif-expression association was discernible in
intergenic and intronic regions of mouse genes, as well as in TSS-
proximal sequences conserved among vertebrate species (see
Methods; results for Zeb1 are shown in Figure S17).
Mechanisms of Transcriptome Aging
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33204Figure 3. Unsupervised clustering of gene expression signatures from humans and mice reveals that aging effects are
predominantly species-specific. We generated gene expression profiles for aging in human and mouse skin and compared these with 25 aging
profiles from human tissues and 28 aging profiles from mouse tissues. All human profiles (black labels) were generated based on data from the
Affymetrix Human Genome U133 Plus 2.0 array platform and all mouse profiles (red labels) were generated based on data from the Affymetrix Mouse
Genome 430 2.0 array platform (Tables S1 and S2). The cluster analysis is based upon a total of 3785 human-mouse transcript pairs, which collectively,
were associated with 3646 unique human genes and 3580 unique mouse genes. All human-mouse transcript pairs were significantly altered by aging
with respect to at least three separate human profiles or at least three separate mouse profiles (FDR-adjusted P,0.05). Heat map colors denote an
adjusted fold-change ratio (old/young) in units of standard deviations to permit visual and quantitative comparison across tissues and species. In
humans, adjusted ratios were obtained by calculating the estimated 40-year fold change (old/young) for each transcript and dividing this ratio by the
standard deviation of all 3785 ratios calculated in a given profile (i.e., each row of the heatmap). Similarly, in mice, adjusted ratios were obtained by
calculating the 2-year fold change (old/young) for each transcript and dividing this ratio by the standard deviation of all 3785 ratios calculated in a
given profile (i.e., each row of the heatmap). Further details on the experimental datasets used to generate human and mouse aging profiles is
provided in the Methods section, Table S1 and Table S2.
doi:10.1371/journal.pone.0033204.g003
Mechanisms of Transcriptome Aging
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mice and decreased in long-lived Pit1(dw/dw) mice
We found that aging has a unique effect in mouse tail skin, as
compared to other tissues, with an unexpectedly weak inflamma-
tory gene expression signature (Figures 5 and S11B). Nevertheless,
we expected that some aspects of tail skin aging would be closely
tied to basic aging mechanisms in other tissues, both in mice and
humans. To identify such responses, we aligned expression
signatures of aging from human and mouse skin (both sexes), in
combination with signatures from a diverse panel of human and
mouse tissues (Figure S18; Tables S1 and S2). Inspection of these
meta-profiles uncovered expression responses to aging that were
similar across many human and mouse tissues (e.g., Clu, Erbb2ip
and C5ORF13/D0H4S114; see Figure S18). The protein-damage
biomarker Clu, for instance, has been linked to Alzheimer’s disease
in genetic association studies [38–41], and was previously
identified as part of a common signature of genes with elevated
expression in aging mammalian tissues [23]. In agreement, our
meta-profiles indicated that Clu expression increased with age in
13 of 27 human aging profiles and 14 of 30 mouse aging profiles
(Figures 9 and S18A). This is a better-supported aging effect than,
for instance, elevated expression of Cdkn2a (p16INK4a) [42], which
was increased by aging in 10 of 27 human profiles but was likewise
elevated in only 4 of 30 mouse profiles (data not shown).
Further evaluation by RT-PCR revealed that Clu is elevated
with age in cardiac tissue (males) and kidney (females) of CB6F1
mice, but surprisingly, decreased with age in ear skin (Figures 9D–
9G). One application of well-supported gene expression biomark-
ers of aging is to judge whether intrinsic aspects of the aging
process have been influenced by genetic or dietary interventions
(e.g., GH/IGF-1 mutations or calorie restriction). As a test of this
concept, we evaluated expression of Clu in GH-deficient Pit1(dw/
dw) mice, which exhibit increased longevity and are viewed as a
mouse model of healthy aging [43]. In both liver and
hypothalamus, expression of Clu was diminished in Pit1(dw/dw)
mice at 6 months of age, consistent with a ‘‘delayed aging’’
phenotype of Pit1(dw/dw) mice (P=0.005; Figures 9H and 9I).
Expression of Clu is thus sensitive to key endocrine pathways that
modulate development of age-related pathology in mice.
Discussion
Senescent decline of skin function provides a model for
understanding basic biological mechanisms of aging that operate
in mammalian organ systems and cell types. We have used
genome-wide expression analysis to identify intercellular (inflam-
matory) and intracellular (cis-regulatory) mechanisms that account
for the large-scale shifts in gene expression observed with intrinsic
aging of human and mouse skin. In female subjects, inflammatory
gene expression was heightened with age, with decreased
expression of genes near regions of high Zeb1, AP-2 and YY-1
motif density. In male subjects, however, these effects were
contrasting and absent, respectively. Such sex disparities were not
observed in mouse tail skin, and at a broad level, there was little
human-mouse correspondence between aging effects. Comparison
of aging signatures across multiple datasets revealed that,
surprisingly, aging in tail skin does not increase expression of
immune response genes typically elevated with age (e.g., Clec7a,
Lyz1, Lyz2, Cd48 and Tyrobp). We thus present a counter-example
to what is the most robust expression signature of aging known to
occur in mice. This unexpected result is consistent with a decline
in the abundance of antigen presenting cells (APCs) with aging of
tail skin in CB6F1 mice, and we propose that this is one factor that
contributes to the observed disparity of aging effects between
human sun-protected skin and mouse tail skin.
Genome-wide expression profiling studies have repeatedly
observed that transcripts elevated with age are linked to
inflammation and immune response [11,23,44–47]. These expres-
sion patterns are probable indicators of inflammation and
infiltration of aging tissues by leukocyte populations [30]. In this
study, we have generated in silico profiles that characterize such
shifts in lymphocyte abundance with aging in both humans and
Figure 4. Weak association between aging effects in sun-protected human skin and tail skin from CB6F1 mice. The expression fold-
change (old/young) over 40 years (human) or 2 years (mouse) was calculated for 15,203 transcripts associated with orthologous human and mouse
genes. The scatterplot shows the human-mouse association between fold change estimates in (A) female human subjects versus female mice and (B)
male human subjects versus male mice. The dashed blue line represents the least squares regression estimate, and the estimated Pearson correlation
(r) is shown in the lower right quadrant (blue font). The yellow region in (A) and (B) outlines the central 50% of data points closest to the bivariate
median (based upon Mahalanobis distance). The grey region outlines the central 80% of data points closest to the bivariate median (based upon
Mahalanobis distance). A bivariate association, if present, would be indicated by an oblong (non-circular) shape of the yellow or grey region. In (A),
the estimated correlation coefficient is significantly negative (r=20.096; P,0.001). In (B), the estimated correlation coefficient is non-significant
(r=20.002; P=0.77). Absence of significant correspondence between human and mouse aging effects was further supported based upon three
other statistical methods for comparing gene expression profiles (see Figures S7, S8 and S9).
doi:10.1371/journal.pone.0033204.g004
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related increase in the expression of transcripts associated with T-
cells, macrophages, DC, monocytes and neutrophils, while males
exhibit decreased expression of transcripts associated with T- and
B-cells (Figures 1 and 2). This sexually dimorphic pattern parallels
that observed in the human central nervous system, with
heightened inflammatory gene expression with aging in females
as compared to males [21]. It is possible that anti-inflammatory
Figure 5. Aging in mouse tail skin leads to an aberrantly weak inflammatory signature with decreased expression of Lyz1, Lyz2,
Clec7a, Cd48, Tyrobp and Mpeg1. Gene expression profiles associated with aging in mouse tail skin (first two columns in chart) were aligned with
28 other aging profiles from a panel of mouse tissues. All profiles were generated from datasets that included young and old mice, where the same
Affymetrix Mouse Genome 430 2.0 array platform was used to generate each dataset (see Methods and Table S2 for further detail). The chart lists in
rank-order the top 50 genes increased by aging across all profiles (based upon the total number of significant (age-increased) results among all
profiles for a given gene). Colors within the chart denote the estimated 2-year fold change (old/young) for a given gene (row) and profile (column)
(see color scale), while up and down-triangles denote significant aging effects (comparison-wise P,0.05). Several alternative versions of this chart
with different gene-ranking schemes are shown in Figure S10.
doi:10.1371/journal.pone.0033204.g005
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this sex disparity in skin and the central nervous system [48–50].
In females, estrogen levels decline with age, but more precipitously
following menopause, while in males, dominance of estrogen
relative to testosterone increases with age in a more continuous
fashion [51]. These temporal dynamics are consistent with the
gene expression signature associated with CD4+ T-cells, which
was age-independent in females prior to the age of 40, and
subsequently exhibited its strongest elevation with respect to the
early 40’s age group (approximately 40–45; see Figure 2B). In
contrast, for male subjects, the CD4+ T-cell signature exhibited a
slight and continuous decline with advancing age (Figure 2D).
Previous work has identified transcription factors associated
with skin aging, including ETS1, ETS2, AP-1, p53, E2F1 and NF-
kB [8,19,27,28]. In this study, we identified motif-expression
associations that include transcription factors not previously
implicated in skin aging mechanisms (e.g., Zeb1, AP-2 and YY1
motifs in female human subjects, see Figures S3 and S4; Zeb1 and
Prrx2 in female and male mice, see Figures 8 and S15). These
results provide data-driven hypotheses for future work, although
we expect that further experimental evaluation will be necessary to
understand the potential regulatory role of these transcription
factors in young versus old skin tissue. Importantly, however, our
findings give emphasis to the sex- and species-specific character of
these motif-expression associations, suggesting that sex and species
must be carefully accounted for both in the analysis of genomic
data and in mechanistic studies of such factors and their
contribution to skin aging. The Zinc finger E-box binding
homeobox 1 (Zeb1) transcription factor provides an illustrative
example. This transcription factor was associated with age-
Figure 6. Clec7a expression is decreased with age in tail skin but increased by age in heart and lung from CB6F1 mice. RT-PCR was
used to evaluate the expression of Clec7a in mice from three age groups (5 months, 17 months and 30 months) and both sexes (n=5–6 mice for each
sex/age combination). The expression of 18S ribosomal RNA (Rn18s) was used as an internal control gene for calculation of relative expression in each
sample. Plots (A)–(F) show mean expression levels in each group (6 one standard error), which have been normalized to the average expression level
of the young (5 month) female group. In each plot, and for each sex, the average expression of middle-aged (17 month) and old groups (30 months)
was compared to that of the young group (5 months). A blue star is used to indicate a significant difference based upon a two-sample non-
parametric statistical test (P,0.05; either Wilcoxon or Kruskal-Wallis rank sum test).
doi:10.1371/journal.pone.0033204.g006
Mechanisms of Transcriptome Aging
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33204decreased expression among (human) female subjects, but not
males (Figures S5A and S5B). In mice, however, Zeb1 motif
abundance was linked to age-increased expression in both males and
females, contrasting strongly with the result obtained in human
females (Figures S16A and S16B). Age-related shifts in estrogen
dominance might contribute to the sex-specific Zeb1-expression
association observed in humans. For instance, the gene encoding
Zeb1 (Tcf8) is induced by estrogen and/or progesterone in chick
oviduct, mouse uterus, human smooth muscle cells, and an
osteosarcoma cell line, although these effects vary among estrogen-
sensitive cell lines [52–54]. These Zeb1-mediated estrogen effects
could impact skin aging phenotypes, since Zeb1 represses cellular
senescence in mouse embryonic fibroblasts [55] and also represses
the synthesis of Col1a1 in osteoblasts [56], Col1a2 in vascular
smooth muscle cells [57], and both Col2a1 and Col11a2 in cartilage
[58,59].
Mechanistic correspondence between senescent processes in
humans and mice is an important issue in aging biology, since
functional studies of individual genes and their influence on aging
frequently use mice, and because mice are used to screen drugs
Figure 7. In silico inflammation profiles of aging in mouse skin and other tissues: Tail skin aging leads to decreased expression of
genes associated with antigen-presenting cells. An algorithm for calculation of inflammation profiles based on microarray data was used to
establish a gene expression-based mapping of inflammation events associated with aging in mouse tail skin (CB6F1 strain) and other tissue types [31]
(see Methods). This figure can be interpreted as described in the Figure 1 legend and is based upon the influence of aging on the expression of
‘‘signature transcripts’’ associated with different cell populations (listed in left margin). Red colors in the chart denote evidence for an age-related
expansion or infiltration of the cell population type listed in each row (sees color scale and Figure 1 legend). The opposite trend is denoted by green
colors (see color scale and Figure 1 legend).
doi:10.1371/journal.pone.0033204.g007
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healthspan in humans [25,26]. Several of our findings are
consistent with a previous study, which reported little broad
correlation between age-associated gene expression patterns in
brain, muscle and kidney tissue from humans and inbred C57BL/
6 mice [24]. One explanation of these results is that aging
processes differ fundamentally between humans and laboratory
mice, possibly due to known effects of laboratory adaptation on the
GH/IGF-1 endocrine pathway in mice [60], or to species
differences in the accumulation of senescent cells and/or oxidative
stress burden with aging [61,62]. However, the following three
points warrant consideration. (i) Transcriptional effects of aging in
skin may depend upon the skin region that is sampled (e.g.,
keratinized versus weakly-keratinized regions) [20]. We cannot
exclude the possibility, therefore, that stronger human-mouse
correspondence would have been observed if other skin regions,
with different histological properties, had been examined from
either human subjects or mice [20]. Indeed, our findings show that
expression of the lysozyme genes (Lyz1 and Lyz2) were decreased
with age in tail skin, but increased with age in ear skin (Figures S12
Figure 8. Top-ranked motifs associated with aging effects in mouse tail skin (CB6F1 strain): Overlap with top-ranked human motifs
but dissimilar associations with aging. The chart lists the top-scoring motifs associated with genes (A) increased by aging of tail skin in female
mice, (B) decreased by aging of tail skin in female mice, (C) increased by aging of tail skin in males, and (D) decreased by aging of tail skin in males.
For each motif (left margin), gene sets associated with a varying number of motif occurrences (in the region 2000 BP upstream/200 BP downstream of
the transcription start site) were derived. For any one motif, gene sets with fewer motif occurrences were always larger than those sets containing
genes with more motif occurrences (see legend in right margin). Thus, larger symbols correspond to larger gene sets with few motif occurrences
while smaller symbols correspond to smaller gene sets with a larger number of motif occurrences (see legend). For each set, the proportion of age-
increased to age-decreased genes was calculated (open symbols and horizontal axis; see Figure S3 and S4 legends). A motif-expression association is
indicated by deviation of this proportion from 0.50, with blue symbols corresponding to gene sets for which the estimated proportion differs
significantly from 0.50 (comparison-wise P,0.05; Fisher’s exact test), and yellow symbols corresponding to sets significant at a more stringent
threshold (FDR-adjusted P,0.05; Bejamini-Hochberg correction). We noted two motif-aging associations that, for the same sex, were consistent in
direction with those identified in humans (blue font; compare with Figures S3 and S4). However, we noted nine associations that, for the same sex,
were contrasting in direction compared to those identified in humans (magenta font; compare with Figures S3 and S4). For each motif listed,
candidate target genes are listed in the right margin (red labels for age-increased genes; green labels for age-decreased genes; see Figure S3 and S4
legends).
doi:10.1371/journal.pone.0033204.g008
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PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e33204Figure 9. Clusterin (Clu) expression is altered by aging in human and mouse organs and Clu expression is decreased in long-lived
Pit1(dw/dw) mice (liver and hippocampus). Plots (A) and (B) display the expression of human clusterin (CLU) relative to age, where each open
circle indicates the microarray-based expression estimate in sun-protected skin from an individual female or male. Red lines correspond to the least
squares estimate for the regression of expression versus subject age, and blue lines represent the same regression but obtained using the Loess
procedure. Panel (C) displays mean microarray-based expression levels of mouse Clu (61 standard error) in tail skin from young (5 month) and old (30
months) CB6F1 mice (n=5 per group). Panels (D)–(G) display average expression of mouse Clu in mice from three age groups (5 months, 17 months
and 30 months) and from both sexes (n=5–6 mice for each sex/age combination; RT-PCR with 18S ribosomal RNA used as an internal control gene
for calculation of relative expression). Each panel (D)–(G) displays the mean expression levels in each group (6 one standard error) normalized to the
average expression level of the young (5 month) female group. For each sex, the average expression of middle-aged (17 month) and old groups (30
months) was compared to that of the young group (5 months). A red star indicates a significant difference relative to the youngest group of the same
sex (P,0.05; two-sided two-sample t-test). A blue star is used to indicate a significant difference based upon a two-sample non-parametric statistical
test (P,0.05; either Wilcoxon or Kruskal-Wallis rank sum test). Panels (H) and (I) display average expression of mouse clusterin (Clu) in long-lived
Pit1(dw/dw) dwarf mice as compared to littermate controls with normal phenotypes (n=6 per genotype; males; six months of age; Actb was used as
an internal reference for calculation of relative expression).
doi:10.1371/journal.pone.0033204.g009
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human and mouse aging effects, we could identify individual genes
and gene sets with relatively species-convergent or species-
divergent aging patterns (see Figures S18 and S19). For instance,
points of convergence include negative regulation of epithelial cell
proliferation, peptide cross-linking, collagen fibril organization and
tumor necrosis factor cytokine production (Figure S19), while
divergent points include positive regulation of ab T-cell activation,
leukocyte cell-cell adhesion, positive regulation of NF-kappaB
transcription factor activity, and autophagy (Figure S19). (iii)
Human-mouse similarity of transcriptional aging effects may be
strengthened if human aging effects are estimated from a cohort
that includes very old individuals. For example, we observed that
(central nervous system) transcriptional aging signatures estimated
from cohorts that include very old subjects (e.g., above 95 years
old) did in fact cluster together with transcriptional aging
signatures derived from mouse brain tissues (see Figure 3). On
the other hand, in the context of experimental aging research,
investigators have argued the counter-point, and have suggested
that very old subjects do not, in fact, provide good models for
understanding basic aging mechanisms [63].
Many datasets have now been generated for characterizing the
aging transcriptomes of humans and mice [11,23,61]. It is
important to emphasize, however, that both technical and
biological factors limit consistency between studies, such as noise
in genome-wide expression assays, idiosyncratic characteristics of
mouse strains, disparities in sample processing methods, and
stochastic aspects of aging processes. We estimate, for instance,
that overlap among results from microarray-based gene expression
studies of aging in human and mouse tissues is typically less than
20% at a comparison-wise type I error rate of 0.05 (Figure S20).
From this perspective, the necessity of meta-analysis for establish-
ing a strong foundation for future work is apparent, and we and
others have emphasized this approach [11,23,61,64]. While no
individual gene exhibits a completely consistent pattern across
datasets, we were able to identify well-supported single-gene
patterns associated with aging in multiple tissues from humans and
mice [11,23,64] (see Figure S18). Our results show, for instance,
that clusterin (Clu) expression is elevated with age in multiple
organs of CB6F1 mice (tail skin, heart and kidney) and that
expression is also diminished in liver and hippocampus of ‘‘slow
aging’’ Snell mice that lack circulating levels of GH and IGF-1
[38–41] (Figure 9). This result underscores a link between a well-
supported age-associated expression pattern and an endocrine
mutation known to alter aging trajectory in mammalian systems.
We anticipate that meta-analyses will, in coming years, further
orient our focus towards high-confidence aging effects with
connections to basic aging mechanisms, and that this may lead
to a more precise operational definition of aging.
Mammalian aging has been linked to a broad range of
pathological processes at the cellular and histological levels,
including inflammation, accumulation of oxidative stress damage,
formation of advanced glycation end products, and diminished
protein homeostasis [65]. In skin, these basic mechanisms of aging
interact with declines in collagen synthesis and collagen degrada-
tion, with progressive declines in the integrity of the extracellular
matrix [8,9]. The transcriptome shifts that occur with aging can
yield new hypotheses for mechanisms that participate in these
processes. Here, we have provided evidence for concerted shifts in
the expression patterns of genes associated with T-cells, B-cells and
dendritic cells with increased age, along with directional shifts in
the expression of genes associated with key transcription factors,
such as Zeb1 in both humans and mice. Interestingly, these trends
had sex- and species-specific characteristics, and in mice, were
coupled to decreased expression of Clec7a, Lyz1 and Lyz2 with
increased age. These findings provide data-driven insight into the
mechanisms that shape the aging transcriptome, which, in turn,
can provide guideposts towards development of more compre-
hensive conceptual models of skin aging. Future studies of these
mechanisms may facilitate development of therapeutics that
improve the likelihood of healthy aging outcomes in mammals.
Methods
Ethics statement
This study was conducted in compliance with good clinical
practice and according to the Declaration of Helsinki principles.
Informed written consent was obtained from all human subjects,
under protocols approved by the institutional review board of the
University of Michigan (HUM00037994). All animal protocols
were approved by the University of Michigan committee on the
use and care of animals (018 ARF 5614).
Microarray analysis of sun-protected human skin
The population cohort and sample processing methods for
human microarray data has been described in a recent report [66].
In brief, 62 healthy individuals were recruited from areas
surrounding Detroit, Michigan between October 2001 and
November 2002 (n=31 women 18–75 years of age; n=31 men
18–60 years of age). Skin biopsies were obtained from the buttock
or upper thigh region, and throughout we have assumed that these
skin regions are relatively sun-protected and thus predominantly
influenced by intrinsic aging rather than the extrinsic ‘‘aging’’
associated with chronic UV light exposure. Processed samples
from each subject were hybridized to Affymetrix Human Genome
U133 Plus 2.0 arrays, which include probe sets corresponding to
54675 human transcripts. Raw microarray data has been
deposited in the NCBI Gene Expression Omnibus database and
is accessible through accession number GSE13355. Human
Genome U133 Plus 2.0 array annotation was obtained from
release 31 of the NetAffx database [67].
Microarray analysis of mouse tail skin (CB6F1 strain)
CB6F1 hybrid mice were obtained from NIA (n=5 males at 5
months of age; n=5 females at 5 months of age; n=5 males at 17
months of age; n=5 females at 17 months of age; n=6 males at 30
months of age; n=6 females at 30 months of age). For these
treatments, ‘‘young’’ mice correspond to those at 5 months of age,
and ‘‘old’’ mice correspond to those at 30 months of age. Median
lifespan for this hybrid mouse strain is reported to be 28.5 months
[68]. Mice were fasted for 6–8 hours and then sacrificed by CO2
inhalation. Upon sacrifice, ear, back and tail skin was collected
along with internal organs, and samples were stored in RNAlater
(Qiagen cat. no. 76106) and placed at 4uC for 24 hours before
transitioning to 220uC. For microarray analyses, we have focused
on mouse tail skin because this region has relatively low density of
hair follicles in correspondence with the more interfollicular nature
of human skin. Additionally, mouse tail skin compares favorably
with human skin due to its relative enrichment in epidermis and
attenuation of the panniculus carnosus, a subcutaneous muscle
layer prominent in dorsal regions of mice but nearly absent in
humans [69]. All samples were disrupted using a rotor-stator
homogenizer and RNA extractions were performed using the
Qiagen RNeasy Fibrous Tissue kit (Qiagen cat. no. 74704), with
on-column DNAase digestion (Qiagen cat. no. 79254). Extracted
RNA was quantified using the NanoDrop spectrophotometer and
RNA quality was evaluated using the Agilent Bioanalyzer.
Processed samples from young and old mice were hybridized to
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include probe sets for more than 39,000 transcripts selected from
GenBank, dbEST and RefSeq. Mouse Genome 430 2.0 array
annotation was obtained from release 31 of the NetAffx database
[67]. Raw data have been deposited in the NCBI Gene Expression
Omnibus database and are accessible through accession number
GSE35322.
Statistical analysis of aging effects in human and mouse
skin
Quality of array hybridizations was evaluated according to
standard metrics, including degradation scores based upon 39 to 59
trends in expression measurements, average background and the
percentage of transcripts with detectable expression levels [70].
Expression scores for all arrays were calculated using robust
multichip average (RMA) [70], and both human and mouse skin
datasets were adjusted for batch effects using Empirical Bayes
methods [71]. In both mice and humans, functions from the
Limma linear modeling package were used to estimate model
coefficients associated with aging effects [72], and FDR-adjusted
p-values were calculated using the Benjamini-Hochberg method
[73]. For mouse tail skin data, aging effects were evaluated by a
two-sample treatment comparison between young and old mice
[72]. With respect to human sun-protected skin, expression values
were available across a continuous span of ages. The effects of
aging on gene expression were thus evaluated using iteratively
reweighted least squares robust regression [74]. This approach
estimates model coefficients by iteratively minimizing a loss
function that assigns reduced weight to larger residuals, thereby
attenuating the influence of outlying observations [74]. To
implement this method, we used the ‘‘robust’’ option in the
‘‘lmFit’’ function from the Limma linear modeling package
(available from Bioconductor) [75], which provides an interface
to the MASS package ‘‘rlm’’ function with default settings [76].
Default settings for the ‘‘rlm’’ function initialize the procedure by
obtaining ordinary least squares coefficient estimates, with
subsequent refitting and reweighting of residuals using the ‘‘Huber
function’’ with coefficient value of 1.345 [74]. Weights for
individual observations were not provided during the initiation
step, such that all observations were weighted equally when
obtaining the initial least square coefficient estimates [76].
Both human and mouse analyses were performed using RMA-
derived scores in which gene expression is quantified on a log2
rather than absolute scale. In human regression analyses, we
expected that expression estimates on the log2 scale would have a
linear association with individual age. For each of the 54,675
probe sets represented on the Human Genome U133 Plus 2.0
array, we evaluated whether including a quadratic term in our
models led to a significant decrease in model deviance (i.e., F-test
for lack of fit) [74], but did not obtain significant evidence in favor
of this type of non-linear association between log2-based gene
expression and individual age (FDR-adjusted P$0.99 for both
sexes). This supported adequacy of the linear regression approach
in this context, and we expected that any opposing trends for some
genes would be mitigated by our use of robust regression analysis
[74,76]. We note, however, that we have estimated 40-year fold-
change in humans and 2-year fold-change in mice on an absolute
scale (e.g., see Figures S1 and S10). For these fold-change
estimates, we have assumed that gene expression changes with age
are linear on an absolute scale. Since this assumption may not be
valid for all genes, our fold-change estimates should be interpreted
as a summary measure, which is accurate in cases for which gene
expression on an absolute scale changes in linear fashion with age,
but represents only the average rate of change across the lifespan
in cases for which gene expression on an absolute scale changes in
non-linear fashion with age.
Overrepresentation of gene ontology (GO) terms within specific
sets of genes was evaluated using a conditional version of Fisher’s
exact test [70,77]. With this approach, significance of a GO term is
evaluated based upon a filtered set of associated genes, which
excludes any gene associated with both that term and a more
specific child term that is already significantly overrepresented.
The main advantage of this approach is that results are
decorrelated with less redundancy within a set of GO terms
identified as significantly overrepresented with respect to genes
increased or decreased by aging. We note, however, that
significant GO terms are identified based upon p-values haven’t
been corrected for multiple hypothesis testing, since an appropri-
ate p-value correction has not yet been established in this context
[70]. In all GO analyses (Figures S2 and S11), overrepresentation
of terms among age-regulated genes was evaluated with respect to
a background of genes with detectable expression in the majority
of human or mouse skin samples (12,500 human genes; 14,681
mouse genes). Presence or absence of transcripts in human or
mouse skin samples was evaluated based upon p-values generated
from the Wilcoxon signed rank test as implemented in the MAS
5.0 algorithm [70,78].
Meta-analysis of age-associated gene expression
patterns
Meta-analysis of age-associated gene expression patterns was
carried out using data available from either the Gene Expression
Omnibus or ArrayExpress databases (accession numbers for human
data: GSE876, GSE5086, GSE9419, GSE9103, GSE11906,
GSE11375, GSE11882, GSE16028, GSE19743; accession numbers
for mouse data: GSE3150, GSE3253, GSE4332, GSE4786,
GSE6591, GSE8150, GSE10000, GSE10965, GSE11291,
GSE11667, GSE13799, GSE21716, GSE22317, E-MEXP-839, E-
MEXP-1504; Tables S1 and S2). Additionally, we have utilized a
complete dataset provided as supplemental material from a previous
study [45]. All datasets used the same Affymetrix oligonucleotide
array platforms that we have utilized to generate expression data in
human and mouse skin(i.e.,the Human Genome U133 Plus2.0 and
Mouse Genome 430 2.0 array platforms). Statistical analysis of aging
effects was carried out using two-sample comparisons (young versus
old) or robust linear regression with age as a single predictor variable
(see above). We have not incorporated cDNA array data from the
AGEMAP project [24] into our analysis because the AGEMAP
cDNA platform provides only partial coverage of the mouse genome
(i.e., 8932 mouse genes), because AGEMAP cDNA array data have
already been meta-analyzed in a previous study [11], and because
differences between Affymetrix oligonucleotide and cDNA array
platforms render direct comparisons difficult to interpret [79–81].
Calculation of human and mouse inflammation profiles
Procedures followed for calculation of inflammation profiles
have been described in a previous publication [31]. To generate
human profiles (Figure 1), a database of 1382 Affymetrix Human
Genome U133 Plus 2.0 array hybridizations was manually
assembled using annotated CEL files downloaded from Gene
Expression Omnibus. In total, the 1382 CEL files belonged to 309
cell population treatments, where each treatment contained two or
more replicate CEL files associated with a given cell population
(average of 1382/309=4.47 replicates per treatment). Signature
transcripts associated with each treatment were identified by
comparison to an independent reference set of 61 samples
(representing treatment A in Figure 2 from [31]), consisting of
array hybridizations involving a heterogeneous collection of
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accession number GSE7307). Likewise, to generate mouse profiles
(Figure 7), a database of 871 Affymetrix Mouse Genome 430 2.0
array hybridizations was manually assembled using annotated
CEL files downloaded from Gene Expression Omnibus. In total,
the 871 CEL files belonged to 317 groups, where each group
contained two or more replicate CEL files associated with a given
cell population (average of 871/317=2.75 replicates per group).
Signature transcripts associated with each treatment were
identified by comparison to an independent reference set of 47
samples (representing treatment A in Figure 2 from [31]),
consisting of array hybridizations that collectively involved a
heterogeneous collection of mouse tissues (e.g., hippocampus,
heart, kidney; see GEO accession number GSE10246). Given
these procedures, signature transcripts associated with a given cell
population treatment (either mouse or human) represent tran-
scripts with high expression in that treatment, as compared to a
diverse panel of other tissue types. Signature transcripts were
identified using two-sample comparisons (cell population versus
reference) and linear modeling methods implemented in the
Limma package [31,72]. For each cell population treatment, the
ratio n1/n2 was calculated, where n1 represents the number of
signature transcripts increased by age, and n2 represents the
number of signature transcripts decreased by age. Additionally, an
adjusted ratio n1*/n2* was also calculated, which is identical to n1/
n2, except only a subset of signature transcripts are utilized in the
calculation [31]. This subset included only those signature
transcripts that were not signature transcripts for any other cell
population with a larger n1/n2 ratio (see Figure 2 and Methods
from [31]). Significant evidence for infiltration or expansion of a
cell population with age was present if both n1/n2 and n1*/n2* were
significantly large (FDR-adjusted P,0.05; Fisher’s Exact test). P-
values generated among all cell populations were adjusted using
the Benjamini-Hochberg procedure [73].
Motif analyses
Human and mouse genome coordinates were obtained from
refGene files downloaded from the UCSC database (human
version hg19, GRCh37, mouse version mm9). Genomic sequences
were derived from Bioconductor BSgenome packages (BSgeno-
me.Hsapiens.UCSC.hg19 and BSgenome.Mmusculu-
s.UCSC.mm9). Position weight matrices (PWMs) were obtained
from the UniPROBE and Jaspar databases [32–34]. For each
nucleotide position within a PWM, ratios of posterior to prior
probabilities were calculated using empirically estimated nucleo-
tide background frequencies (see Table S3). Input sequences were
scored for matches to a given PWM by summing log2-transformed
(posterior/prior) probability ratios across nucleotide positions
within the PWM, and a match was called for sequence regions
with scores exceeding 90% of the maximum score for the PWM
[82]. If overlapping sequence matches to a given motif were
identified, such overlapping matches were not double-counted but
were instead counted as a single match in all genome scans.
Initial screens considered PWM matches only within genomic
regions 2000 bp upstream and 200 bp downstream of annotated
transcription start sites (Figures S3, S4, 7 and S15). Based on
results of these initial screens, a selected subset of top-ranking
motifs were further investigated with respect to all intergenic, all
intronic and conserved sequence regions 2000 bp upstream of the
TSS for each gene (Zeb1, AP-2 and YY1 motifs in human; Zeb1
and Prrx2 motifs in mouse; Figures S6 and S17). For human, we
screened a total of 19,494 intergenic regions and 191,912 intronic
regions for matches to the selected PWMs (irrespective of sequence
conservation). Likewise, for mouse we screened a total of 20,079
intergenic regions and 179,146 intronic regions (irrespective of
sequence conservation). Human conserved sequences (#2000 bp)
upstream of transcription start sites were obtained from UCSC
multiple alignments of 45 vertebrate genomes (hg19, GRCh37).
Mouse conserved sequences (#2000 bp) upstream of transcription
start sites were obtained from UCSC multiple alignments of 29
vertebrate genomes (mm9). For analyses of intergenic, intronic and
conserved sequences (Figures S6 and S17), sequence lengths were
variable and we noted a correlation between PWM match counts
and sequence length. To remove this effect, we calculated a
length-adjusted count score for each sequence, which was
proportional to the density of PWM matches within a given
sequence. Length-adjusted scores were calculated as the residual
values in a Poisson regression model, with PWM counts as the
response variable and sequence length (ln-transformed) as a single
predictor variable. Average length-adjusted scores were then
compared between foreground and background sequence sets as
described in Figure S6 and S17 legends.
Supporting Information
Figure S1 Ranked lists of genes altered by aging in skin
and other human tissues. Tables display age-associated
expression patterns for ranked lists of the top 50 genes (A)
increased by aging across all human tissues, (B) decreased by aging
across all human tissues, (C) increased by aging in human skin, or
(D) decreased by aging in human skin. For a given gene (row) and
tissue (column), colors denote the estimated fold-change expression
ratio (old/young) between an individual t+40 years of age and an
individual t years of age (a linear rate of change with age is
assumed). Filled triangles indicate whether genes were significantly
increased or decreased by aging (P,0.05). Tables (A) and (B) list
genes most frequently regulated by aging across all human tissues,
with genes ranked according to the total number of significant
results obtained across all columns in each table (i.e., the total
number of up or down triangles per row). Genes for which
expression is similarly altered in human skin are indicated by an
asterisk symbol. Tables (C) and (D) list genes most strongly
regulated by aging in skin specifically, with genes first filtered to
include only genes significantly altered by age in both sexes
(P,0.05 in each sex), and then ranked according to the estimated
40-year fold-change (i.e., old/young; averaged between males and
females). Genes for which expression is similarly altered in three or
more other human aging profiles are indicated by an asterisk
symbol.
(PDF)
Figure S2 Gene ontology biological process terms
associated with human skin aging and their association
with aging across human tissues. Genes regulated by aging
in human skin were analyzed to identify significantly over-
represented gene ontology (GO) biological process terms
(P,0.05; Fisher’s exact test). The analysis was performed based
upon (A) a set of 2469 human genes increased by aging in female
skin (P,0.05), (B) a set of 2578 human genes decreased by aging in
female skin (P,0.05), (C) a set of 2199 human genes increased by
aging in male skin and (D) a set of 1113 human genes decreased by
aging in male skin (P,0.05). The font color of each GO term in
the left margin corresponds to the degree to which that term was
overrepresented (P,0.05, black font; P,0.01, blue font; P,0.001,
red font). For each GO term, colors within the chart denote the
average 40-year fold change (old/young) among genes associated
with that GO term. The number of genes associated with each
GO term is indicated in brackets (this total only includes genes that
are among the 2469, 2578, 2199 or 1113 genes analyzed in parts
Mechanisms of Transcriptome Aging
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average fold-change estimates among these genes are significantly
high (up-triangle; P,0.05) or significantly low (down-triangle;
P,0.05). Triangles are displayed only if significant p-values were
obtained from each of three separate tests evaluating whether the
average fold-change estimate (or distribution of estimates) is
significantly high or low (i.e., one-sample t-test, exact binomial
proportion test and Wilcoxon signed rank test; triangles denote
P,0.05 in each test). GO terms have been clustered based upon a
similarity metric that is proportional to the number of shared
ancestral terms in the GO hierarchy.
(PDF)
Figure S3 Sex-specific associations of transcription
factor binding site motifs with the gene expression
response to aging in human skin. The chart lists top-scoring
motifs associated with genes (A) increased by aging in female
subjects, (B) decreased by aging in female subjects and (C)
increased by aging in male subjects. A total of 541 position weight
matrices (PWMs) associated with mammalian transcription factors
were obtained from the Jaspar and UniPROBE databases. For
each PWM, regions proximal to the annotated transcription start
site (TSS) of known human genes were scanned to identify putative
binding sites (2000 BP upstream, 200 BP downstream). Based on
results from this scan, we identified genes associated with varying
numbers of binding sites (1…n) for a given motif. The figure
provides a ‘‘threshold-free’’ display of trends relating binding site
abundance to age-associated gene expression patterns. We derived
a series of gene sets (x1, x2… xn), where the first set x1 contained
genes with at least one binding site in the search region, set x2
contained genes with at least two binding sites, and so on, with set
xn containing genes with at least n binding sites. The number of
genes belonging to each set declined successively in the series
spanning set x1 to xn. The number of sets evaluated in this fashion
(n) varied among the 541 PWMs considered, since more complex
PWM models had fewer genome matches within search regions.
For each PWM and each gene set, the proportion of genes
increased by aging in females (A and B) or males (C) was evaluated
(horizontal axis). For sets x1, x2,…, xn, this proportion is
represented by open circles, with blue circles representing sets
for which the ratio of age-increased to age-decreased genes is
significantly different from 0.50 (P,0.05; Fisher’s exact test), and
yellow circles representing sets for which the ratio is significant at a
more stringent threshold (FDR-adjusted P,0.05; Benjamini-
Hochberg method). Circle size corresponds to the number of
genes included in each set (see legend in right margin), where
larger symbols denote larger sets of genes with fewer PWM motif
matches, and smaller circles denote smaller sets of genes with more
PWM motif matches. In parts (A)–(C), PWMs have been ranked
according to the most extreme ratio (i.e., most different from 0.50)
obtained for any set including at least 100 genes. For each age-
associated motif, candidate target genes are listed in the right
margin (red and green font). Candidate target genes were
identified as those strongly altered by aging (P,0.05), with a
maximal number of motif occurrences within the search region
(age-increased genes in red font; age-decreased genes in green
font). We noted that two top-scoring motifs (blue font, left margin)
exhibited a similar relationship with aging in female versus male
skin, while for one motif (magenta font, left margin) there was a
contrasting relationship with aging in females versus males. Motifs
associated with age-decreased expression in males are not shown
because no gene sets with ratios (no. age-increased genes/no. age-
decreased genes) significantly less than 0.50 were identified in
males.
(TIF)
Figure S4 Sex-specific associations of transcription
factor binding site motifs with the gene expression
response to aging in human skin. This figure is identical to
Figure S3, except a simulation-based correction for multiple
testing has been applied (yellow symbols). For each simulation
trial, genes were randomly assigned to gene sets (631 sets in total),
where the respective size of gene sets was matched to those
evaluated in our analysis. Following this random assignment of
genes to gene sets, p-values were generated from each set to test for
age-biased expression (Fisher’s Exact Test), and the lowest p-value
arising among all gene sets was identified. This procedure was
repeated in 2000 simulations, yielding a distribution for the
minimum p-value expected to arise by chance alone, given the
total number of gene sets evaluated for age-biased expression. We
then identified the 0.05 quantile of this distribution (P*), which
corresponds to the p-value that is lower than the minimal p-value
that arose in 95% of the simulation trials. Those gene sets
associated with p-values less than P* are denoted by yellow
symbols.
(TIF)
Figure S5 Zeb1, AP-2 and YY1 binding site density near
the TSS is associated with decreased gene expression
with age in females but not males. In each figure, blue or
black symbols represent the average 40-year fold-change (old/
young) among genes with at least t binding sites in the region
proximal to the annotated transcription state site (2KB upstream
and 200 BP downstream of the TSS). An increasing series of
thresholds (t) was used to define gene sets of successively smaller
sizes (horizontal axis), and for each set, the average 40-year fold-
change was calculated (vertical axis). The background color (red or
green) reflects the proportion of age-increased (red) to age-
decreased genes (green) with respect to a given threshold (t), where
an increase in the size of the red region denotes a higher
proportion of age-increased genes with increasing t, and an
increase in the size of the green region denotes a higher proportion
of age-decreased genes with increasing t. For any given threshold t,
blue symbols denote gene sets for which the average 40-year fold-
change among genes with at least t binding sites is significantly
different from that of genes with fewer than t binding sites
(P,0.05; two-sample t-test). The dotted horizontal line represents
the average 40-year fold-change (old/young) among all 18,442
human genes included in the analysis.
(TIF)
Figure S6 Genomic regions with increased AP-2 binding
site density are associated with decreased gene expres-
sion with age in female human subjects but not male
subjects. These analyses were performed with respect to all
human non-coding intergenic regions (repeat-masked) (parts A–
D), all intronic regions (repeat-masked) (parts E–H), and conserved
sequences located 2000 BP upstream of the annotated TSS for all
human genes (parts I–L). In each case, sequences were scanned to
identify putative AP-2 binding sites (consensus motif: GCC----G),
and length-adjusted residual scores were calculated for all
sequences (see Methods). Positive scores indicate a large number
of AP-2 binding sites (given sequence length) and negative scores
indicate a small number of AP-2 binding sets (given sequence
length). Average residual scores were then compared between a
foreground set of sequences (adjacent to age-increased or age-
decreased genes) and a background set of sequences (i.e., all other
sequences excluding those in the foreground). The central
tendency of the foreground sequence residual scores is displayed
for (A, E, I) sequences within or adjacent to age-increased genes
(red lines) in females, (B, F, J) sequences within or adjacent to age-
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within or adjacent to age-increased genes (red lines) in males, and
(D, H, L) sequences within or adjacent to age-decreased genes in
males (green lines). In each case, red or green lines represent the
average residual score among foreground sequences (middle line)
along with 95% confidence interval bounds (lower and upper
lines). The grey region outlines a 95% confidence interval for the
residual scores among sequences in the background set. Significant
differences between the average foreground and background
residual score are noted by blue bars near the top or bottom of
each figure. Analyses were repeated using foreground sequence
sets of varying size and selectivity (see horizontal axis). The
smallest and most selective foreground set (leftmost-side of each
figure) included only sequences adjacent to genes strongly altered
by aging in the appropriate direction (based upon ranked p-values
obtained from tests for an aging effect). The largest and least
selective foreground set (rightmost-side of each figure) included
sequences that were altered by aging in the appropriate direction,
but were not necessarily adjacent to genes strongly altered by
aging (based upon ranked p-values obtained from tests for an aging
effect).
(PDF)
Figure S7 Weak association between aging effects in
sun-protected human skin and tail skin from CB6F1
mice (adjusted residuals). A set of 15,203 human-mouse
orthologous transcript pairs were placed into one of nine
categories (horizontal axis in each panel) depending on whether
transcripts were increased by aging (P,0.05; red up-triangles),
decreased by aging (P,0.05; green down-triangles) or not altered
by aging (black dash) in human sun-protected skin and/or tail skin
from CB6F1 mice. For each category, an adjusted residual was
calculated (vertical axis), which reflects departure from random
association between human and mouse differential expression
signatures (see Swindell [11]). Positive residuals indicate an
overabundance of human-mouse transcript pairs within a
particular category, while negative residuals indicate under-
abundance of human-mouse transcript pairs within a category.
Under the null hypothesis (random association between human
and mouse differential expression results), adjusted residuals are
expected to follow a standard normal distribution, with residuals
larger than three in absolute value providing evidence for a
significant association between species. Correspondence between
human-mouse aging patterns would have been supported by
positive residuals for transcript pairs increased or decreased in
both species (i.e., the fourth and third categories from the right), or
alternatively, by negative residuals for transcript pairs with
conflicting aging effects in the two species (i.e., the last two
categories on the right).
(TIF)
Figure S8 Weak association between aging effects in
sun-protected human skin and tail skin from CB6F1
mice (AUC statistics). 15,203 mouse transcripts were ranked
according to the strength of aging effects among orthologous
human genes in sun-protected skin (horizontal axis). This ranking
was based upon (A) the degree of increase with aging in human
females, (B) the degree of decrease with aging in human females,
(C) the degree of increase with aging in human males or (D) the
degree of decrease with aging in human males. In each panel (A)–
(D), mouse transcripts associated with the strongest aging effect in
humans (with respect to the human orthologue) were assigned
lower ranks. Foreground sets of 200 mouse transcripts were then
identified as those most strongly (A) increased with aging in mouse
females, (B) decreased with aging in mouse females, (C) increased
with aging in mouse males and (D) decreased with aging in mouse
males. Red or green curves track the cumulative overlap (vertical
axis) between the 200 foreground transcripts and the ranked set of
15,203 mouse transcripts. Enrichment of foreground genes with
respect to the ranked lists (horizontal axis) is supported by red or
green curves above the diagonal line, with a large positive area
between the colored line and the diagonal (i.e., the region shaded
in grey). This area is proportional to the Wilcoxon-Mann-Whitney
(WMW) statistic, and for a large set of foreground genes chosen at
random, is expected to follow a standard normal distribution (see
equations 5–7 from Philippakis et al. [35]). The standard normal
was therefore used as a null distribution to evaluate the
significance of WMW statistics obtained in (A)–(D) and to generate
the p-value listed in the lower-right of each panel.
(TIF)
Figure S9 Weak association between aging effects in
sun-protected human skin and tail skin from CB6F1
mice (Gene Set Enrichment Analysis). 15,203 mouse
transcripts were ranked according to the strength of aging effects
among orthologous human genes in sun-protected skin (horizontal
axis). This ranking was based upon (A) the degree of increase with
aging in human females, (B) the degree of decrease with aging in
human females, (C) the degree of increase with aging in human
males or (D) the degree of decrease with aging in human males. In
each panel (A)–(D), mouse transcripts associated with the strongest
aging effect in humans (with respect to the human orthologue)
were assigned lower ranks. Foreground sets of 200 mouse
transcripts were then identified as those most strongly (A)
increased with aging in mouse females, (B) decreased with aging
in mouse females, (C) increased with aging in mouse males and (D)
decreased with aging in mouse males. The enrichment (vertical
axis) is a measure of the cumulative overlap between the
foreground set of mouse transcripts and the ranked list of 15,203
mouse transcripts (see Subramanian et al. [36]). The enrichment
score (ES) metric is the maximum enrichment observed across all
ranked genes (see red circle) and is used as the test statistic. The
null distribution of ES was generated from 1000 simulation trials
in which the 15,203 mouse transcripts were ranked based upon
randomized expression data. The shaded grey region within each
panel represents the lower 95% of the simulated null distribution
for ES. Correspondence between human-mouse aging patterns is
not supported in (A)–(D) because the red circle (ES) shown in each
panel lies within the grey region (i.e., within the lower 95% of the
ES null distribution).
(TIF)
Figure S10 Ranked lists of genes altered by aging in
mouse tail skin and other tissues. Tables display age-
associated expression patterns for ranked lists of the top 50 genes
(A) increased by aging across all mouse tissues, (B) decreased by
aging across all mouse tissues, (C) increased by aging in mouse tail
skin (CB6F1 strain), or (D) decreased by aging in mouse tail skin
(CB6F1 strain). For a given gene (row) and tissue (column), colors
denote the estimated fold-change expression ratio between an
older mouse t+2 years of age and a younger mouse t years of age (a
linear rate of change with age is assumed). Filled triangles denote
significant aging effects (P,0.05). In (A) and (B), gene rankings are
based upon the total number of significant results observed across
all columns in each table, and an asterisk symbol is used to denote
genes similarly altered between mouse skin (males and/or females)
and the other aging profiles. In (C) and (D), genes were first filtered
to include only those significantly altered by aging in skin
(P,0.05), and then ranked according to fold-change estimates
(old/young) (averaged between sexes). Genes for which expression
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(PDF)
Figure S11 Gene ontology biological process terms
associated with mouse tail skin aging (CB6F1 strain).
Genes regulated by aging in mouse tail skin were analyzed to
identify significantly over-represented gene ontology (GO) biolog-
ical process terms (P,0.05; Fisher’s exact test). The analysis was
performed based upon (A) a set of 2633 mouse genes significantly
increased by aging in females (P,0.05), (B) a set of 3134 mouse
genes significantly decreased by aging in females (P,0.05), (C) a
set of 2509 mouse genes significantly increased by aging in males
(P,0.05) and (D) a set of 3208 mouse genes significantly decreased
by aging in males (P,0.05). The font color of each GO term in the
left margin corresponds to the degree to which that term was
overrepresented (P,0.05, black font; P,0.01, blue font; P,0.001,
red font). For each GO term, colors within the chart denote the
average 2-year fold change (old/young) among genes associated
with that GO term. The number of genes associated with each
GO term is indicated in brackets (this total only includes genes that
are among the 2633, 3134, 2509 or 3208 genes analyzed in parts
A, B, C and D, respectively). Filled triangles indicate whether
average fold-change estimates among these genes are significantly
high (up-triangle; P,0.05) or significantly low (down-triangle;
P,0.05). Triangles are displayed only if significant p-values were
obtained from each of three separate tests evaluating whether the
average fold-change estimate (or distribution of estimates) is
significantly high or low (i.e., one-sample t-test, exact binomial
proportion test and Wilcoxon signed rank test; triangles denote
P,0.05 in each test). GO terms have been clustered based upon a
similarity metric that is proportional to the number of shared
ancestral terms in the GO hierarchy.
(PDF)
Figure S12 Lyz1 expression is not elevated with age in
tail skin but increased by age in ear skin, heart and
kidney from CB6F1 mice. RT-PCR was used to evaluate the
expression of Lyz1 in mice from three age groups (5 months, 17
months and 30 months) and from both sexes (n=5–6 mice for
each sex/age combination). The expression of 18S ribosomal
RNA (Rn18s) was used as an internal control gene for calculation
of relative expression in each sample. Plots (A)–(F) show mean
expression levels in each group (6 one standard error) normalized
to the average expression level of the young (5 month) female
group. In each plot, and for each sex, the average expression of
middle-aged (17 month) and old groups (30 months) was
compared to that of the young group (5 months). A red star
indicates a significant difference relative to the youngest group of
the same sex (P,0.05; two-sided two-sample t-test). A blue star is
used to indicate a significant difference based upon a two-sample
non-parametric statistical test (P,0.05; either Wilcoxon or
Kruskal-Wallis rank sum test).
(TIF)
Figure S13 Lyz2 expression is not elevated with age in
tail skin but increased by age in ear skin, heart, kidney
and small intestine from CB6F1 mice. RT-PCR was used to
evaluate the expression of Lyz2 in mice from three age groups (5
months, 17 months and 30 months) and from both sexes (n=5–6
mice for each sex/age combination). The expression of 18S
ribosomal RNA (Rn18s) was used as an internal control gene for
calculation of relative expression in each sample. Plots (A)–(F)
show mean expression levels in each group (6 one standard error)
normalized to the average expression level of the young (5 month)
female group. In each plot, and for each sex, the average
expression of middle-aged (17 month) and old groups (30 months)
was compared to that of the young group (5 months). A red star
indicates a significant difference relative to the youngest group of
the same sex (P,0.05; two-sided two-sample t-test). A blue star is
used to indicate a significant difference based upon a two-sample
non-parametric statistical test (P,0.05; either Wilcoxon or
Kruskal-Wallis rank sum test).
(TIF)
Figure S14 Aging of mouse tail skin leads to decreased
expression of transcripts associated with dendritic cells
but increased expression of CD4+ T cell-associated
genes (CB6F1 strain). We identified 500 probe sets (from the
Affymetrix Mouse Genome 430 2.0 Array) associated with
signature transcripts that exhibit high expression in CD4+ T-cells
isolated from spleen (based upon data provided under GEO series
accession GSE20366). Likewise, we identified 500 probe sets
associated with transcripts that exhibit high expression in dendritic
cells harvested from lung tissue (GSE18607). The scatterplots (A)–
(D) display expression of these transcripts in tail skin samples from
young (5 month) and old (30 month) CB6F1 mice of both sexes
(n=5 per age group for each sex). In each scatterplot, red symbols
represent probe sets with higher expression in old mice, while
green symbols represent probe sets with higher expression in
young mice. The relative proportion of these two probe set groups
is indicated by the pie chart shown in each panel.
(TIF)
Figure S15 Top-ranked motifs associated with aging
effects in mouse tail skin (CB6F1 strain): Overlap with
top-ranked human motifs but dissimilar associations
with aging. This figure is identical to Figure 8, except a
simulation-based correction for multiple testing has been applied
(yellow symbols). For each simulation trial, genes were randomly
assigned to gene sets (625 sets in total), where the respective size of
gene sets was matched to those evaluated in our analysis.
Following this random assignment of genes to gene sets, p-values
were generated from each set to test for age-biased expression
(Fisher’s Exact Test), and the lowest p-value arising among all gene
sets was identified. This procedure was repeated in 2000
simulations, yielding a distribution for the minimum p-value
expected to arise by chance alone, given the total number of gene
sets evaluated for age-biased expression. We then identified the
0.05 quantile of this distribution (P*), which corresponds to the p-
value that is lower than the minimal p-value that arose in 95% of
the simulation trials. Those gene sets associated with p-values less
than P* are denoted by yellow symbols.
(TIF)
Figure S16 Zeb1 and Prrx2 motif density near the TSS is
associated with age-related expression patterns in tail
skin from both sexes (CB6F1 strain). In each figure, blue or
black symbols represent the average 2-year fold-change (old/
young) among genes with at least t binding sites in the region
proximal to the annotated transcription start site (2 KB upstream
and 200 BP downstream of the TSS). An increasing series of
thresholds (t) was used to define gene sets of successively smaller
sizes (horizontal axis), and for each set, the average 2-year fold-
change was calculated (vertical axis). The background color (red or
green) reflects the proportion of age-increased (red) to age-
decreased genes (green) with respect to a given threshold (t), where
an increase in the size of the red region denotes a higher
proportion of age-increased genes, and an increase in the size of
the green region denotes a higher proportion of age-decreased
genes. For any given threshold t, blue symbols denote gene sets for
which the average 2-year fold-change among genes with at least t
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than t binding sites (P,0.05; two-sample t-test). The dotted
horizontal line represents the average 2-year fold-change (old/
young) among all 17, 329 mouse genes included in the analysis.
(TIF)
Figure S17 Genomic regions with increased Zeb1 motif
density are associated with increased gene expression
with aging of tail skin from both sexes (CB6F1 strain).
The panels (A)–(L) compare Zeb1 motif density between sequences
adjacent to or within genes exhibiting increased (or decreased)
expression with age (i.e., foreground sequences), relative to
sequences adjacent to or within genes that exhibit decreased (or
increased) expression with age (i.e., background sequences) (i.e., as
described in the AP-2 analysis shown in Figure S6). For each
sequence examined, a length-adjusted residual score was calculat-
ed, which is proportional to the density of Zeb1binding sites within
that sequence. Each panel shows the average residual score among
sequences adjacent to or within age-increased genes (see red lines
and 95% confidence intervals in A, C, E, G, I and K) or the
average residual score among sequences adjacent to or within age-
decreased genes (see green lines and 95% confidence intervals in
B, D, F, H, J and L). The grey region in each panel outlines a 95%
confidence interval for the average residual score among
sequences assigned to the background set (which includes all
sequences not within the foreground set). The analysis was
repeated based upon foreground sets of varying size and selectivity
(horizontal axis; see Figure S6 legend). A significant motif-
expression association is indicated by non-overlap between 95%
confidence intervals associated with foreground and background
gene sets (denoted by blue bars located near the top or bottom of
each panel).
(PDF)
Figure S18 Ranked lists of genes altered by aging in
both human and mouse tissues. Tables display age-
associated expression patterns for ranked lists of the top 50 genes
most strongly (A) increased by aging across all human tissues, (B)
decreased by aging across all human tissues, (C) increased by aging
in human skin (both sexes), (D) decreased by aging in human skin
(both sexes), (E) increased by aging across all mouse tissues, (F)
decreased by aging across all mouse tissues, (G) increased by aging
in mouse skin (both sexes) and (H) decreased by aging in mouse
skin (both sexes). In each figure (A)–(H), age-associated gene
expression patterns in human tissues are displayed in the left panel,
and age-associated gene expression patterns in mouse tissues are
displayed in the right panel. Ranked lists include only orthologous
genes that are shared between humans and mice (and thus may
differ from those presented in Figures S1 and S10). In (A), (B), (E)
and (F), genes have been ranked according to the total number of
significant results observed for a given gene across human and
mouse tissues (i.e., the total number of up-triangles per row or the
total number of down-triangles per row). Tables (C), (D), (G) and
(H) list genes most strongly regulated by aging in skin specifically,
with genes first filtered to include only genes significantly altered
by age in both sexes of a given species (P,0.05), and then ranked
according to the estimated 40-year or 2-year fold-change (old/
young; averaged between males and females).
(PDF)
Figure S19 Biological processes associated with concor-
dant and discordant age-associated expression patterns
in human sun-protected skin and mouse tail skin. Figures
(A) and (B) list gene ontology (GO) biological process terms
significantly overrepresented (P,0.05) among genes with (A)
concordant or (B) discordant age-associated expression patterns in
humans and mice. The analysis was performed based upon (A)
2190 genes concordantly altered by aging in humans and mice
(i.e., increased or decreased in the same sex of both species;
P,0.05 for each species) and (B) 644 genes altered discordantly
altered by aging in humans and mice (i.e., increased in one species
and decreased in the other for the same sex; P,0.05 per species).
GO terms in both (A) and (B) have been clustered based upon a
similarity metric that is proportional to the number of shared
ancestral terms in the GO hierarchy. For each term, an exemplar
gene is listed in parentheses, which exhibits either a corresponding
(in part A) or non-corresponding (in part B) expression pattern in
humans and mice. As an alternative strategy (Figures C–F), we
scored 5242 GO biological process terms (all GO terms associated
with orthologous genes in humans and mice), and identified those
for which the direction of aging effects (i.e., increase or decrease)
was most similar or discordant in human and mouse skin (i.e.,
regardless of whether genes were significantly altered by aging in
either species; see Figures C–F). For each GO term selected in this
fashion, figures (C)–(F) display the proportion of age-increased and
age-decreased genes in each species (red and green bars). The right
margin of Figures (C)–(F) lists three exemplar genes associated with
the selected terms.
(PDF)
Figure S20 The overlap among sets of age-regulated
genes derived from different datasets with young and
old tissues is characteristically 10–15%. We calculated the
pairwise overlap between sets of age-regulated genes derived from
(A) 27 datasets that included young and old human tissue samples
and (B) 30 datasets that included young and old mouse tissue
samples. All human datasets considered in part (A) were generated
from the same Affymetrix Human Genome U133 Plus 2.0 array
platform (Table S1), and all mouse datasets considered in part (B)
used the same Affymetrix Mouse Genome 430 2.0 Array platform
(Table S2). Further details on each dataset included are provided
in the Methods section. In both (A) and (B), datasets used to derive
sets of age-regulated genes are listed along the horizontal axis. The
height of each corresponding grey bar indicates the percentage of
genes significantly altered by age (either increased or decreased),
based upon a comparison-wise Type I error rate of P,0.05, such
that approximately 5% of genes are expected to be age-regulated
by chance (see yellow background behind grey bars). For each
dataset, red and green dots indicate the percent overlap between
the set of age-regulated genes identified from that dataset as
compared to the others included in the same figure. Percent
overlap is defined as 1006(x/y), where x is the number of unique
genes significantly altered by age (in the same direction) in two
separate datasets, and y is the number of unique genes significantly
altered by age in the reference dataset listed along the horizontal
axis. Red dots indicate overlap with respect to sets of age-increased
genes, while green dots indicate overlap with respect to sets of age-
decreased genes. In (A), we evaluated gene set overlap among all 351
pairwise combinations among the 27 human datasets, and on
average, overlap between sets of age-regulated genes was 11.4%,
with a minimum of 0.50% and a maximum of 66.5%. In (B), we
evaluated gene set overlap among all 435 pairwise combinations
among the 30 mouse datasets, and on average, overlap between
sets of age-regulated genes was 12.5%, with a minimum of 0.40%
and a maximum of 54.3%.
(PDF)
Table S1 Human datasets (Affymetrix Human Genome
U133 Plus 2.0 array). This table lists datasets used to evaluate
the effects of aging on gene expression in skin and other human
tissues. The table includes experimental details for each dataset
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significantly altered by aging (P,0.05 and FDR-adjusted P,0.05).
(PDF)
Table S2 Mouse Datasets (Affymetrix Mouse Genome
430 2.0 array). This table lists datasets used to evaluate the
effects of aging on gene expression in skin and other mouse tissues.
The table includes experimental details for each dataset along with
information on the number of genes identified as significantly
altered by aging (P,0.05 and FDR-adjusted P,0.05).
(PDF)
Table S3 Empirical estimates of nucleotide frequency
background distributions (human hg19 and mouse
mm9). Human and mouse genomes were searched to identify
matches with respect to position weight matrices representing
motifs associated with known mammalian transcription factors.
This table lists the region-specific estimates of the nucleotide
frequency background distribution used for the calculation of
position weight matrices.
(PDF)
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